DK193588A - Anvendelser af dopaminagonister - Google Patents

Anvendelser af dopaminagonister

Info

Publication number: DK193588A
Authority: DK; Denmark
Prior art keywords: dopaminagonists; applications
Prior art date: 1987-04-10

Application number

DK193588A

Other languages

English (en)

Other versions

DK193588D0 (da

Inventor

Rudolf Markstein

Jose Palacios

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-04-10

Filing date

1988-04-08

Publication date

1988-10-11

1987-04-10 Priority claimed from GB878708626A external-priority patent/GB8708626D0/en

1987-04-14 Priority claimed from GB878708898A external-priority patent/GB8708898D0/en

1987-04-28 Priority claimed from GB878710062A external-priority patent/GB8710062D0/en

1987-08-28 Priority claimed from GB878720366A external-priority patent/GB8720366D0/en

1988-04-08 Application filed by Sandoz Ag filed Critical Sandoz Ag

1988-04-08 Publication of DK193588D0 publication Critical patent/DK193588D0/da

1988-10-11 Publication of DK193588A publication Critical patent/DK193588A/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK193588A 1987-04-10 1988-04-08 Anvendelser af dopaminagonister DK193588A (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB878708626A GB8708626D0 (en)	1987-04-10	1987-04-10	Indolophenanthridines
GB878708898A GB8708898D0 (en)	1987-04-14	1987-04-14	Indolophenanthridines
GB878710062A GB8710062D0 (en)	1987-04-28	1987-04-28	Indolophenanthridines
GB878720366A GB8720366D0 (en)	1987-08-28	1987-08-28	Dopamine d1 receptor agonists

Publications (2)

Publication Number	Publication Date
DK193588D0 DK193588D0 (da)	1988-04-08
DK193588A true DK193588A (da)	1988-10-11

Family

ID=27449909

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK193588A DK193588A (da)	1987-04-10	1988-04-08	Anvendelser af dopaminagonister

Country Status (11)

Country	Link
US (1)	US4855306A (da)
JP (1)	JPS63258819A (da)
KR (1)	KR880012227A (da)
AU (1)	AU1440088A (da)
DE (1)	DE3811274A1 (da)
DK (1)	DK193588A (da)
FR (1)	FR2613623A1 (da)
GB (1)	GB2205495A (da)
IT (1)	IT1219906B (da)
NL (1)	NL8800823A (da)
SE (1)	SE8801275L (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001514663A (ja) *	1997-03-12	2001-09-11	エスモンド，ロバートダブリュー．	アルツハイマー病を処置または予防するための方法
US20040058873A1 (en) *	1998-03-12	2004-03-25	Esmond Robert W.	Method for treating or preventing Alzheimer's disease
US6362371B1 (en) *	1998-06-08	2002-03-26	Advanced Medicine, Inc.	β2- adrenergic receptor agonists
DE10148233A1 (de) *	2001-09-28	2003-04-10	Boehringer Ingelheim Pharma	Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
US20050215552A1 (en) *	2002-05-17	2005-09-29	Gadde Kishore M	Method for treating obesity
KR20110043664A (ko) *	2002-05-17	2011-04-27	듀크 유니버시티	비만치료방법
DE10312809A1 (de) *	2003-03-21	2004-09-30	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern
US20040266794A1 (en) *	2003-03-21	2004-12-30	Boehringer Ingelheim International Gmbh	Pramipexole for the reduction of excessive food intake for children
EP2316456B1 (en)	2003-04-29	2017-06-14	Orexigen Therapeutics, Inc.	Compositions for affecting weight loss comprising an opioid antagonist and bupropion
EP1626703A2 (en) *	2003-05-22	2006-02-22	Yeda Research And Development Co. Ltd.	Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells
JP2007517901A (ja) *	2004-01-13	2007-07-05	デューク・ユニバーシティー	体重の減少に作用する鎮痙剤及び抗精神病剤の組成物
US7713959B2 (en) *	2004-01-13	2010-05-11	Duke University	Compositions of an anticonvulsant and mirtazapine to prevent weight gain
US20050277579A1 (en) *	2004-05-03	2005-12-15	Ranga Krishnan	Compositions for affecting weight loss
WO2006119353A2 (en) *	2005-05-03	2006-11-09	University Of South Carolina	Dopamine receptor agonists in the treatment and prevention of hiv-induced dementia
PT2135603E (pt)	2005-11-22	2013-04-03	Orexigen Therapeutics Inc	Composições e métodos para aumentar a sensibilidade à insulina
US8916195B2 (en)	2006-06-05	2014-12-23	Orexigen Therapeutics, Inc.	Sustained release formulation of naltrexone
AU2007319472B2 (en)	2006-11-09	2013-01-17	Nalpropion Pharmaceuticals Llc	Methods Of Administering Weight Loss Medications
KR101479324B1 (ko)	2006-11-09	2015-01-05	오렉시젠 세러퓨틱스 인크.	신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
EP2303025A4 (en)	2008-05-30	2012-07-04	Orexigen Therapeutics Inc	METHOD FOR TREATING DIGITAL FAT SWITCHES
CN102482374B (zh) *	2009-08-27	2014-08-27	大金工业株式会社	加工助剂、成型用组合物、加工助剂用母料和成型品
US9248123B2 (en)	2010-01-11	2016-02-02	Orexigen Therapeutics, Inc.	Methods of providing weight loss therapy in patients with major depression
KR20200035501A (ko)	2012-06-06	2020-04-03	오렉시젠 세러퓨틱스 인크.	과체중 및 비만의 치료 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3402392A1 (de) *	1984-01-25	1985-08-01	Sandoz-Patent-GmbH, 7850 Lörrach	Neue ergolinderivate, deren herstellung und deren verwendung

1988
- 1988-03-31 NL NL8800823A patent/NL8800823A/nl not_active Application Discontinuation
- 1988-04-01 FR FR8804499A patent/FR2613623A1/fr not_active Withdrawn
- 1988-04-02 DE DE3811274A patent/DE3811274A1/de not_active Withdrawn
- 1988-04-05 IT IT47814/88A patent/IT1219906B/it active
- 1988-04-07 US US07/178,668 patent/US4855306A/en not_active Expired - Fee Related
- 1988-04-07 GB GB08808125A patent/GB2205495A/en active Pending
- 1988-04-08 AU AU14400/88A patent/AU1440088A/en not_active Abandoned
- 1988-04-08 DK DK193588A patent/DK193588A/da not_active Application Discontinuation
- 1988-04-08 SE SE8801275A patent/SE8801275L/ not_active Application Discontinuation
- 1988-04-09 JP JP63088033A patent/JPS63258819A/ja active Pending
- 1988-04-09 KR KR1019880004023A patent/KR880012227A/ko not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE3811274A1 (de)	1988-10-27
IT1219906B (it)	1990-05-24
DK193588D0 (da)	1988-04-08
GB8808125D0 (en)	1988-05-11
US4855306A (en)	1989-08-08
FR2613623A1 (fr)	1988-10-14
SE8801275A0 (sv)	1988-10-19
GB2205495A (en)	1988-12-14
SE8801275L (sv)	1988-10-19
KR880012227A (ko)	1988-11-26
AU1440088A (en)	1988-10-13
JPS63258819A (ja)	1988-10-26
NL8800823A (nl)	1988-11-01
IT8847814A0 (it)	1988-04-05
SE8801275D0 (sv)	1988-04-08

Publication	Publication Date	Title
DK193588D0 (da)	1988-04-08	Anvendelser af dopaminagonister
DK208188D0 (da)	1988-04-15	Anvendelse af 17-ketosteroider
DK450189D0 (da)	1989-09-12	Strimmel af sammenfoejede soem
DK363887D0 (da)	1987-07-13	Anvendelse af bromcruptin
DK348385A (da)	1986-02-03	Anvendelse af cyclosporiner
DK662687D0 (da)	1987-12-16	Anvendelse af tricycliske carbazoloner
DK549688A (da)	1989-04-02	Fremstilling af peptider
DK25389D0 (da)	1989-01-20	Tolkning af elektriske diagrafier
DK185988D0 (da)	1988-04-06	Anvendelse af antigen
DK360484A (da)	1985-01-26	Modifikation af soja-isolat
DK38593D0 (da)	1993-03-31	Alkoxymethylethere af glyceroler
DK102389A (da)	1989-09-05	Anvendelse af interleukin
DK119688D0 (da)	1988-03-04	23-oxo- (-keto-) og 23-imino-derivater af mono- og diepoxy-ll-f28249-forbindelser
DK316589D0 (da)	1989-06-26	Substituerede azacyclohexylderivater af rifamyciner
DK104489D0 (da)	1989-03-03	Anvendelse af triazolderivater
DK562289A (da)	1990-05-12	Anvendelse af somatostatiner
DK541487D0 (da)	1987-10-16	Sammenfoejning af materialer
DK293787A (da)	1987-12-11	Ekspression af en amyloglucosidase
DK426089D0 (da)	1989-08-30	Omestring af phospholipider
DK251788D0 (da)	1988-05-06	Stabile creatinamidinohydrolasemutanter
DK105089D0 (da)	1989-03-03	Fremstilling af bis(amin-holdige)benzendioler
DK487289D0 (da)	1989-10-04	Omestring af phospholipider
DK153045C (da)	1988-10-31	Sammenkobling af fortrinsvis langstrakte elementer
DK621088D0 (da)	1988-11-08	Theemballage af theposetypen
DK531987D0 (da)	1987-10-12	Oprensning af antistoffer

Legal Events

Date	Code	Title	Description
1991-12-16	AHB	Application shelved due to non-payment